Re: Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancer.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 11203074)

Published in J Urol on November 01, 2000

Authors

C Stephan, K Jung, M Lein, D Schnorr, S A Loening

Articles by these authors

Betaine improves the PCR amplification of GC-rich DNA sequences. Nucleic Acids Res (1997) 3.32

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer (2008) 2.67

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest (1997) 2.39

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma. Proc Natl Acad Sci U S A (1998) 2.29

Probing proton dynamics in molecules on an attosecond time scale. Science (2006) 2.24

European and US publications in the 50 highest ranking pathology journals from 2000 to 2006. J Clin Pathol (2007) 2.20

Both long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosis. Atherosclerosis (2007) 2.16

Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int J Cancer (1997) 2.11

Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J Clin Oncol (2004) 2.07

Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia (2005) 1.99

Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers. J Rheumatol (1999) 1.88

Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection (2003) 1.78

The mechanical effect of blocking screws ("Poller screws") in stabilizing tibia fractures with short proximal or distal fragments after insertion of small-diameter intramedullary nails. J Orthop Trauma (1999) 1.75

Regulation of RssB-dependent proteolysis in Escherichia coli: a role for acetyl phosphate in a response regulator-controlled process. Mol Microbiol (1998) 1.74

Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4-HS66 strain of human norovirus. J Virol (2007) 1.70

Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4. J Natl Cancer Inst (2001) 1.59

Role of mitochondria and C-terminal membrane anchor of Bcl-2 in Bax induced growth arrest and mortality in Saccharomyces cerevisiae. FEBS Lett (1996) 1.59

Quality of life of living kidney donors in Germany: a survey with the Validated Short Form-36 and Giessen Subjective Complaints List-24 questionnaires. Transplantation (2004) 1.59

Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood. Clin Chim Acta (2001) 1.58

Successful living related kidney transplantation despite renal angiomyolipoma in situ. J Urol (1999) 1.57

Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis. Ann Neurol (2001) 1.57

Phylogenetic analysis of swine influenza viruses recently isolated in Korea. Virus Genes (2008) 1.52

Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin Chem (1999) 1.49

Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: results of a prospective phase I trial. Int J Hyperthermia (2007) 1.48

Isoforms of prostate-specific antigen in serum: a result of the glycosylation process in dysplastic prostatic cells? Prostate (1996) 1.46

Isolation and phylogenetic analysis of H1N1 swine influenza virus isolated in Korea. Virus Res (2006) 1.45

The use of Poller screws as blocking screws in stabilising tibial fractures treated with small diameter intramedullary nails. J Bone Joint Surg Br (1999) 1.44

Properties and purification of an active biotinylated lactose permease from Escherichia coli. Proc Natl Acad Sci U S A (1993) 1.43

Laparoscopic radical cystectomy with continent urinary diversion (rectal sigmoid pouch) performed completely intracorporeally: the initial 5 cases. J Urol (2001) 1.42

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer (2008) 1.41

PhaF, a polyhydroxyalkanoate-granule-associated protein of Pseudomonas oleovorans GPo1 involved in the regulatory expression system for pha genes. J Bacteriol (1999) 1.40

Laparoscopic partial nephrectomy: initial experience and comparison to the open surgical approach. J Urol (1995) 1.40

Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Differ (2006) 1.39

Complications of laparoscopic procedures in urology: experience with 2,407 procedures at 4 German centers. J Urol (1999) 1.39

A gap between total prostate-specific antigen and the sum of free prostate-specific antigen plus alpha1-antichymotrypsin-prostate- specific antigen in patients with prostate carcinoma but not in those with benign prostate hyperplasia. Clin Chem (1999) 1.38

Multiple sclerosis and Chlamydia pneumoniae. Ann Neurol (2000) 1.37

Diagnostic sensitivity of serum cystatin for impaired glomerular filtration rate. Pediatr Nephrol (1999) 1.32

The value of magnetic resonance imaging in the diagnosis of suspected penile fracture with atypical clinical findings. J Urol (1996) 1.32

The lactose permease meets Frankenstein. J Exp Biol (1994) 1.32

Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues. Br J Cancer (2003) 1.25

Cysteine 148 in the lactose permease of Escherichia coli is a component of a substrate binding site. 1. Site-directed mutagenesis studies. Biochemistry (1994) 1.20

Hematopoietic and reproductive hazards of Korean electronic workers exposed to solvents containing 2-bromopropane. Scand J Work Environ Health (1996) 1.19

One-step multiplex RT-PCR for detection and subtyping of swine influenza H1, H3, N1, N2 viruses in clinical samples using a dual priming oligonucleotide (DPO) system. J Virol Methods (2008) 1.18

Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 1.17

Extracorporeal shock wave lithotripsy: multicenter study of kidney and upper ureter versus middle and lower ureter treatments. J Urol (1994) 1.17

Unidirectional reconstitution and characterization of purified Na+/proline transporter of Escherichia coli. Biochemistry (1998) 1.15

Inhibition of cyclin-dependent kinase 4 (Cdk4) by fascaplysin, a marine natural product. Biochem Biophys Res Commun (2000) 1.15

Molecular forms of prostate-specific antigen and human kallikrein 2 as promising tools for early diagnosis of prostate cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.12

Evaluation of chicken-origin (DF-1) and quail-origin (QT-6) fibroblast cell lines for replication of avian influenza viruses. J Virol Methods (2008) 1.11

Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue. Urology (2000) 1.10

Interspecies transmission of the canine influenza H3N2 virus to domestic cats in South Korea, 2010. J Gen Virol (2011) 1.10

What's new with lactose permease. J Bioenerg Biomembr (1993) 1.10

Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol (1998) 1.08

Laparoscopic radical prostatectomy. Technical aspects and experience with 125 cases. Eur Urol (2001) 1.06

Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology (2001) 1.05

Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone. Cancer (1983) 1.04

Cystatin C: a promising marker of glomerular filtration rate to replace creatinine. Nephron (1995) 1.03

An optimized assay of alanine aminopeptidase activity in urine. Clin Chem (1980) 1.03

Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. Invest Urol (1978) 1.03

Measurements of UV-generated free radicals/reactive oxygen species (ROS) in skin. Spectrochim Acta A Mol Biomol Spectrosc (2006) 1.02

Estradiol signaling via sequestrable surface receptors. Endocrinology (2001) 1.02

Modulation of KdpD phosphatase implicated in the physiological expression of the kdp ATPase of Escherichia coli. Mol Microbiol (2000) 1.01

Results of a double blind study of 89-strontium therapy of skeletal metastases of prostatic carcinoma. Eur J Nucl Med (1988) 1.00

Influence of age on duodenal brush border membrane and specific activities of brush border membrane enzymes in Wistar rats. Exp Anim (2000) 0.99

Bladder cancer: factors affecting survival. J Urol (1983) 0.99

A conformational change in the lactose permease of Escherichia coli is induced by ligand binding or membrane potential. Protein Sci (1994) 0.99

Dimethyl sulfoxide as additive in ready-to-use reaction mixtures for real-time polymerase chain reaction analysis with SYBR Green I dye. Anal Biochem (2001) 0.99

Disease-free and overall survival after cryosurgical monotherapy for clinical stages B and C carcinoma of the prostate: a 20-year followup. J Urol (1997) 0.99

Refinements of assays for low concentrations of inulin in serum. Nephron (1990) 0.99

Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J Biol Chem (2001) 0.98

Regulation of L-carnitine metabolism in Escherichia coli. J Basic Microbiol (1987) 0.97

Early urinary markers of target nephron segments as studied in cadmium toxicity. Kidney Int Suppl (1994) 0.97

Are cystatin C and beta 2-microglobulin better markers than serum creatinine for prediction of a normal glomerular filtration rate in pediatric subjects? Clin Chem (1997) 0.96

Ratio of free or complexed prostate-specific antigen (PSA) to total PSA: which ratio improves differentiation between benign prostatic hyperplasia and prostate cancer? Clin Chem (2000) 0.96